Literature DB >> 14174526

CASE FINDING IN PHENYLKETONURIA. II. THE GUTHRIE TEST.

M W PARTINGTON, B SINNOTT.   

Abstract

Experience with over 6000 Guthrie tests is presented. This test is a screening procedure for phenylketonuria using small amounts of blood spotted on a filter paper which are tested by a bacterial "inhibition assay". Certain technical aspects of the test (e.g. relation between the concentration of phenylalanine in the blood and extent of the bacterial growth zones produced, type of filter paper, size of the blood spot on the paper) were investigated. It was shown that the Guthrie test clearly distinguishes between subjects with normal plasma phenylalanine levels and patients with untreated phenylketonuria.Applications of the Guthrie test in screening a mental hospital population, admissions to a penitentiary and newborn babies are described.

Entities:  

Keywords:  BACTERIOLOGICAL TECHNICS; CANADA; DIAGNOSIS, LABORATORY; HOSPITALS; INFANT, NEWBORN, DISEASES; MASS SCREENING; PHENYLALANINE; PHENYLKETONURIA; PRISONS; URINE

Mesh:

Substances:

Year:  1964        PMID: 14174526      PMCID: PMC1927280     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  16 in total

1.  Cincinnati phenylketonuria detection program--a progress note.

Authors:  H K BERRY; B S SUTHERLAND; G M GUEST
Journal:  JAMA       Date:  1961-11-25       Impact factor: 56.272

2.  Problems of routine screening for phenylketonuria.

Authors:  J W FARQUHAR; E T KANSAS; H P TAIT
Journal:  Lancet       Date:  1962-09-08       Impact factor: 79.321

3.  Atypical phenylketonuria in sisters with normal offspring.

Authors:  L I WOOLF; C OUNSTED; D LEE; M HUMPHREY; N M CHESHIRE; G R STEED
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

4.  Phenylketonuria: screening programs and testing methods.

Authors:  W R CENTERWALL; R F CHINNOCK; A PUSAVAT
Journal:  Am J Public Health Nations Health       Date:  1960-11

5.  A familial disturbance of histidine metabolism.

Authors:  H GHADIMI; M W PARTINGTON; A HUNTER
Journal:  N Engl J Med       Date:  1961-08-03       Impact factor: 91.245

6.  Minimal media for quantitative studies with Bacillus subtilis.

Authors:  A L DEMAIN
Journal:  J Bacteriol       Date:  1958-05       Impact factor: 3.490

7.  Phenylpyruvic oligophrenia (phenylketonuria).

Authors:  G A JERVIS
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1954

8.  Studies on phenylpyruvic oligophrenia; phenylpyruvic acid content on blood.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1952-12

9.  Assay of L-phenylalanine as phenylethylamine after enzymatic decarboxylation; application to isotopic studies.

Authors:  S UDENFRIEND; J R COOPER
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

10.  Variations in intelligence in phenylktonuria.

Authors:  M W PARTINGTON
Journal:  Can Med Assoc J       Date:  1962-04-21       Impact factor: 8.262

View more
  5 in total

1.  Phenylketonuria. Mass screening of newborns in Ireland.

Authors:  S F Cahalane
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

2.  Population screening by Guthrie test for phenylketonuria in South-east Scotland. Report by the consultant paediatricians and medical officers of health of the S.E. Scotland Hospital Region.

Authors: 
Journal:  Br Med J       Date:  1968-03-16

3.  Case-finding in phenylketonuria: 3. One-way paper chromatography of amino acids in blood.

Authors:  M W Partington
Journal:  Can Med Assoc J       Date:  1968-10-05       Impact factor: 8.262

4.  Phenylketonuria-the guthrie screening test-a method of quantitation, observations on reliability and suggestions for improvement.

Authors:  C M Blumenfeld; M J Wallace; R Anderson
Journal:  Calif Med       Date:  1966-12

Review 5.  Emerging trends in paper spray mass spectrometry: Microsampling, storage, direct analysis, and applications.

Authors:  Benjamin S Frey; Deidre E Damon; Abraham K Badu-Tawiah
Journal:  Mass Spectrom Rev       Date:  2019-09-06       Impact factor: 10.946

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.